LabCompass

James F. Chmiel

Medicine · Indiana University

OpenAlex ORCID
Cystic Fibrosis Research AdvancesAsthma and respiratory diseasesNeonatal Respiratory Health ResearchPediatric health and respiratory diseasesTracheal and airway disorders

Publications

203

Citations

9,558

Est. group size

~1

Recurring co-author estimate

Active years

60

Publishing since 1967

Research summary
AI-generated

James F. Chmiel conducts clinical and translational research on cystic fibrosis, a genetic disease that causes thick mucus buildup and chronic lung problems. Much of the work involves clinical trials testing new therapies to reduce lung inflammation and infection, as well as studies of related respiratory conditions such as asthma. The research spans drug efficacy and safety trials, airway cell biology, and pediatric pulmonary health.

Cystic fibrosis clinical trialsAirway inflammation and infectionPediatric respiratory healthAsthma and inflammatory biomarkersAirway epithelial cell biology

Publication activity has been fairly steady over the past decade, generally in the range of several papers per year with some year-to-year fluctuation.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.4/year recently
2017: 10 publications10172018: 6 publications182019: 7 publications192020: 8 publications202021: 8 publications212022: 2 publications222023: 10 publications10232024: 7 publications242025: 5 publications252026: 3 publications26
Recent publications
Publishes in
  • Journal of Cystic Fibrosis×17
  • New England Journal of Medicine×4
  • The Lancet Respiratory Medicine×3
  • Proceedings of IMPRS×3
  • Journal of Allergy and Clinical Immunology×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile